tiprankstipranks
Iradimed Corp (IRMD)
NASDAQ:IRMD
US Market
IRMD
Iradimed
RESEARCH TOOLSreports
Want to see IRMD full AI Analyst Report?

Iradimed (IRMD) Ratios

177 Followers

Iradimed Ratios

IRMD's free cash flow for Q4 2025 was $0.75. For the 2025 fiscal year, IRMD's free cash flow was decreased by $ and operating cash flow was $0.31. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 7.98 7.98 8.84 4.65 9.06
Quick Ratio
 6.84 6.84 7.62 3.87 8.43
Cash Ratio
 5.03 5.03 6.14 3.05 6.78
Solvency Ratio
 1.71 1.76 1.74 0.87 1.14
Operating Cash Flow Ratio
 2.45 2.45 3.01 0.82 1.17
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
$ 67.05M$ 67.05M$ 63.74M$ 55.27M$ 65.65M
Leverage Ratios
Debt-to-Assets Ratio
 0.00 0.00 <0.01 0.02 0.03
Debt-to-Equity Ratio
 0.00 0.00 <0.01 0.03 0.03
Debt-to-Capital Ratio
 0.00 0.00 <0.01 0.03 0.03
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.15 1.15 1.13 1.29 1.16
Debt Service Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Interest Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
 0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
 0.00 0.00 0.01 0.16 0.18
Net Debt to EBITDA
 -1.77 -1.79 -2.29 -2.29 -3.42
Profitability Margins
Gross Profit Margin
76.75%76.75%76.94%76.50%77.45%
EBIT Margin
32.39%31.20%29.99%30.56%29.32%
EBITDA Margin
34.52%34.04%31.11%31.73%30.58%
Operating Profit Margin
31.20%31.20%29.99%30.56%29.32%
Pretax Profit Margin
33.84%33.84%33.14%33.16%30.36%
Net Profit Margin
26.82%26.82%26.26%26.22%24.07%
Continuous Operations Profit Margin
26.82%26.82%26.26%26.22%24.07%
Net Income Per EBT
79.26%79.26%79.23%79.09%79.28%
EBT Per EBIT
108.47%108.47%110.52%108.50%103.54%
Return on Assets (ROA)
20.67%20.67%19.56%18.66%15.00%
Return on Equity (ROE)
23.83%23.76%22.15%24.07%17.41%
Return on Capital Employed (ROCE)
26.52%26.52%24.46%26.42%20.31%
Return on Invested Capital (ROIC)
21.02%21.02%19.34%20.78%16.04%
Return on Tangible Assets
21.33%21.33%20.20%19.18%15.37%
Earnings Yield
2.11%1.82%2.76%2.87%3.61%
Efficiency Ratios
Receivables Turnover
 6.13 6.13 6.94 5.36 4.02
Payables Turnover
 10.71 10.71 8.91 8.29 6.68
Inventory Turnover
 1.68 1.68 1.62 1.20 2.24
Fixed Asset Turnover
 3.51 3.51 4.32 5.79 11.57
Asset Turnover
 0.77 0.77 0.74 0.71 0.62
Working Capital Turnover Ratio
 1.17 1.22 1.16 1.02 0.77
Cash Conversion Cycle
 243.05 243.05 236.39 327.85 199.30
Days of Sales Outstanding
 59.52 59.52 52.61 68.06 90.90
Days of Inventory Outstanding
 217.61 217.61 224.76 303.80 163.03
Days of Payables Outstanding
 34.08 34.08 40.98 44.00 54.63
Operating Cycle
 277.13 277.13 277.37 371.85 253.93
Cash Flow Ratios
Operating Cash Flow Per Share
 1.96 1.96 2.02 1.07 0.80
Free Cash Flow Per Share
 1.32 1.35 1.39 0.43 0.65
CapEx Per Share
 0.64 0.61 0.63 0.64 0.15
Free Cash Flow to Operating Cash Flow
 0.67 0.69 0.69 0.41 0.81
Dividend Paid and CapEx Coverage Ratio
 1.08 1.09 1.18 0.63 0.70
Capital Expenditure Coverage Ratio
 3.06 3.21 3.20 1.68 5.36
Operating Cash Flow Coverage Ratio
 0.00 0.00 165.65 6.59 4.55
Operating Cash Flow to Sales Ratio
 0.30 0.30 0.35 0.21 0.19
Free Cash Flow Yield
1.57%1.39%2.53%0.91%2.30%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 47.28 55.05 36.23 34.80 27.70
Price-to-Sales (P/S) Ratio
 12.73 14.77 9.51 9.13 6.67
Price-to-Book (P/B) Ratio
 11.23 13.08 8.03 8.38 4.82
Price-to-Free Cash Flow (P/FCF) Ratio
 63.46 72.03 39.55 109.62 43.51
Price-to-Operating Cash Flow Ratio
 42.60 49.61 27.20 44.43 35.39
Price-to-Earnings Growth (PEG) Ratio
 3.01 3.35 3.08 1.04 0.81
Price-to-Fair Value
 11.23 13.08 8.03 8.38 4.82
Enterprise Value Multiple
 35.09 41.59 28.30 26.47 18.39
Enterprise Value
 1.02B 1.19B 644.78M 550.54M 299.65M
EV to EBITDA
 35.21 41.59 28.30 26.47 18.39
EV to Sales
 12.16 14.16 8.80 8.40 5.62
EV to Free Cash Flow
 60.63 69.05 36.59 100.87 36.69
EV to Operating Cash Flow
 40.84 47.56 25.16 40.89 29.84
Tangible Book Value Per Share
 7.16 7.17 6.61 5.47 5.70
Shareholders’ Equity Per Share
 7.43 7.44 6.85 5.67 5.86
Tax and Other Ratios
Effective Tax Rate
 0.21 0.21 0.21 0.21 0.21
Revenue Per Share
 6.58 6.59 5.78 5.20 4.24
Net Income Per Share
 1.76 1.77 1.52 1.36 1.02
Tax Burden
 0.79 0.79 0.79 0.79 0.79
Interest Burden
 1.04 1.08 1.11 1.08 1.04
Research & Development to Revenue
 0.04 0.04 0.04 0.04 0.04
SG&A to Revenue
 0.42 0.42 0.43 0.23 0.20
Stock-Based Compensation to Revenue
 0.03 0.03 0.03 0.03 0.03
Income Quality
 1.11 1.11 1.33 0.78 0.78
Currency in USD